Gold quantum dots impair the tumorigenic potential of glioma stem-like cells via β-catenin downregulation in vitro
Authors Wahab R, Kaushik N, Khan F, Kaushik NK, Lee SJ, Choi EH, Al-Khedhairy AA
Received 20 November 2018
Accepted for publication 4 January 2019
Published 13 February 2019 Volume 2019:14 Pages 1131—1148
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Thomas J Webster
Rizwan Wahab,1,2,* Neha Kaushik,3,* Farheen Khan,4 Nagendra Kumar Kaushik,5 Su-Jae Lee,3 Eun Ha Choi,5 Abdulaziz A Al-Khedhairy1
1Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; 2Al-Jeraisy, Chair for DNA Research, King Saud University, Riyadh 11451, Saudi Arabia; 3Department of Life Science, Hanyang University, Seoul 04763, South Korea; 4Chemistry Department, Faculty of Science, Taibah University, Yanbu 42353, Saudi Arabia; 5Plasma Bioscience Research Center/Applied Plasma Medicine Center, Department of Electrical and Biological Physics, Kwangwoon University, Seoul 01897, South Korea
*These authors contributed equally to this work
Background: Over the past several decades, the incidence of solid cancers has rapidly increased worldwide. Successful removal of tumor-initiating cells within tumors is essential in the field of cancer therapeutics to improve patient disease-free survival rates. The biocompatible multivarient-sized gold nanoparticles (MVS-GNPs) from quantum dots (QDs,
Methods: Herein, MVS-GNPs synthesized and characterized by means of X-ray diffraction pattern (XRD) and transmission electron microscopy (TEM) techniques. Afterwards, interaction of these GNPs with glioma stem-cell like cells along with cancer cells were evaluated by MTT, cell motility, self-renewal assays and biostatistics was also applied.
Results: Among these GNPs, G-QDs contributed to reduce metastatic events and spheroid cell growth, potentially blocking the self-renewal ability of these cells. This study also uncovers the previously unknown role of the inhibition of CTNNB1 signaling as a novel candidate to decrease the tumorigenesis of glioma spheroids and subsequent spheroid growth. The accurate and precise biostatistics results were obtained at quantify level.
Conclusion: In summary, G-QDs may exhibit possible contribution on suppressing the growth of tumor-initiating cells. These data reveal a unique therapeutic approach for the elimination of residual resistant stem-like cells during cancer treatment.
Keywords: multivarient gold nanoparticles, epithelial-mesenchymal transition, solid tumor, brain cancer, self-renewal, cellular movement, biostatistics
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]